These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 3874198

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro activity of CGP 31523A, a broad-spectrum cephalosporin, in comparison with those of other agents.
    Wise R, Cross C, Andrews JM.
    Antimicrob Agents Chemother; 1984 Dec; 26(6):876-80. PubMed ID: 6524904
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro and in vivo evaluation of Ro 09-1428, a new parenteral cephalosporin with high antipseudomonal activity.
    Arisawa M, Sekine Y, Shimizu S, Takano H, Angehrn P, Then RL.
    Antimicrob Agents Chemother; 1991 Apr; 35(4):653-9. PubMed ID: 1906261
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro activity of cefodizime.
    Knothe H, Shah PM.
    Infection; 1992 Apr; 20 Suppl 1():S3-8. PubMed ID: 1526673
    [Abstract] [Full Text] [Related]

  • 8. In vitro activity of CGP 31608, a new penem.
    Wise R, Andrews JM, Piddock LJ.
    Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
    Wise R, Andrews JM, Ashby JP, Thornber D.
    J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents.
    Wise R, Andrews JM, Piddock LJ.
    J Antimicrob Chemother; 1985 Feb; 15(2):193-200. PubMed ID: 3980309
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibacterial properties of SCE-2787, a new cephem antibiotic.
    Nakao M, Noji Y, Iwahi T, Yamazaki T.
    J Antimicrob Chemother; 1992 May; 29(5):509-18. PubMed ID: 1624391
    [Abstract] [Full Text] [Related]

  • 17. In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
    Watanabe N, Katsu K, Moriyama M, Kitoh K.
    Antimicrob Agents Chemother; 1988 May; 32(5):693-701. PubMed ID: 3134847
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Affinity of E1077, a new cephalosporin, for penicillin-binding proteins of Staphylococcus aureus and its antistaphylococcal activity.
    Watanabe N, Katsu K.
    J Antibiot (Tokyo); 1993 Nov; 46(11):1707-15. PubMed ID: 8270493
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.